The area of clinical research known as CNS (central nervous system conditions) is commonly cited for its complexity and the subjective nature of many assessment tools. CNS clinicians therefore must commit to tackling unique challenges affecting their patients and the research they conduct.
It should be no surprise that the life sciences companies that develop therapies for these conditions prioritize standardization and consistency with their prescribing clinicians.
However, it may surprise you to discover how underprepared many healthcare professionals are to effectively screen, assess, diagnose, and treat CNS patients without the ongoing intervention and educational support provided by these life science companies.
Many of the leading biopharmaceutical companies that develop therapies for CNS, like autism, ADHD, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, schizophrenia, and depression rely on Ready by ArcheMedX to help them better equip, train, and assess the clinicians responsible for the research – and delivery – of these novel treatments.
And as the annual CNS Summit approaches, the ArcheMedX team has released highly anticipated new findings about how important effective training is for medical professionals in these therapeutic areas.
Biopharma companies have used the Ready platform to assess and train over 12,000 clinicians at various stages in the CNS therapy life cycle, including clinical trial start up, market development, and clinical practice.
And across these 12,000+ clinicians, ArcheMedX analyzed their readiness against key learning objectives, as well as their improvement after completing training activities using the Ready platform.
The platform identified that 91% did not demonstrate sufficient proficiency to conduct subjective assessments prior to completing training
91% of CNS clinicians need more tailored training on therapies
These data revealed a surprising number of clinicians were not adequately prepared to conduct subjective assessments in clinical trials, or in practice across CNS therapies.
By assessing more than 12,000 clinicians treating CNS conditions as they engaged in on-demand activities powered by Ready, the platform identified that 91% did not demonstrate sufficient proficiency to conduct subjective assessments prior to completing training.
This risk can be reduced by delivering more tailored and impactful education that improves readiness across key learning objectives. Fortunately, these clinicians demonstrated a significant increase in their knowledge and confidence after participating in personalized and highly engaging online training Activities powered by Ready with content provided by trial sponsors and accredited medical educators.
With Ready by ArcheMedX, clinicians increased their mastery of key learning objectives by more than 10x. In one example, they reduced their misunderstanding about screening and diagnosing CNS treatments by 88%.
Using Ready to deliver CNS content improves clinician capabilities measurably
After completing these CNS specific education and training activities with Ready by ArcheMedX, clinicians increased their mastery of key learning objectives by more than 10x. In one example, they reduced their misunderstanding about screening and diagnosing CNS treatments by 88%.
Ready achieves this impact by:
- Transforming your content (i.e., protocols, study documents, or training materials) into an interactive and tailored learning experience.
- Analyzing clinician engagement and behavior as they learn.
- Measuring changes in learner behavior, knowledge, and confidence.
- Delivering targeted remediation to clinicians on-demand.
- Assessing clinician readiness – to help you identify who is prepared to apply knowledge in the field.
More details are available for download now
Meet the ArcheMedX team at the CNS Summit
Those attending the CNS Summit in Boston, November 7th-9th, can schedule an in-person meeting with the ArcheMedX team. Click here to confirm a time.